Healthcare
M6P Therapeutics – SUCCESS PAGE -July 23, 2024
M6P has developed a breakthrough technology that is driving the development of next generation enzyme replacement therapies.
M6P has developed a breakthrough technology that is driving the development of next generation enzyme replacement therapies.
Mitra Chem is creating a sustainable, North American battery materials supply chain to electrify transportation and energy storage.
IDC Ventures backs industry-defining founders from series A to growth stages across Europe, The U.S. and Latin America.
Repair Bio has developed a cholesterol degrading platform that has the potential to reverse atherosclerosis and many other diseases
A Fireside Chat on the future of autonomous vehicles and the technology that will drive them with leading experts in the field
Deep sea nodule collection provides higher quality critical minerals with significantly lower environmental impact than traditional mining.
A first-in-class therapy for Duchenne Muscular Dystrophy allows boys to maintain muscle function and improve quality of life
Barn2Door, powered by a female founder and investors, is serving 1000 Farms across all 50 states with more than $100M in transactions.
Caliber’s vertically integrated investment service model produces diversified revenue streams which provide multiple avenues for earnings growth
Aruna Bio has developed AB126, the first exosome to receive FDA clearance for an IND in neurological disease
Mitra Chem is creating a sustainable, North American battery materials supply chain to electrify transportation and energy storage.
By putting agents first, La Rosa has expanded to include 2500 agents in 37 offices across 7 states with many more coming on board in 2024.